Re: New breast cancer vaccine provides evidence of immunotherapy in preventing diseas
I checked the dates for the phase II, both AE37 & GP2:
Estimated Enrollment: 600 Study Start Date: January 2007 Estimated Study Completion Date: December 2015 Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
I'm only familiar with E75 being in Phase III. If anyone gets news about a Phase III for AE37 or GP2 please share.
|